CRM
PTEN icon

Cramer Rosenthal McGlynn’s Patterson-UTI PTEN Stock Holding History

Cramer Rosenthal McGlynn’s Portfolio PTEN Stock Details PTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-699,280
Closed -$16.1M – 149
2017
Q4 		$16.1M Sell
699,280
-33,200
-5% -$688K 0.26% 118
2017
Q3 		$15.3M Buy
732,480
+105,170
+17% +$1.94M 0.25% 124
2017
Q2 		$12.7M Buy
627,310
+245,380
+64% +$5.35M 0.19% 135
2017
Q1 		$9.27M Buy
+381,930
New +$10.3M 0.14% 155

Other funds holding PTEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $18.4B AUM 23.98% 1-Year Est. Return

Cramer Rosenthal McGlynn's PTEN Position: Q1 2018 in Review

Cramer Rosenthal McGlynn sold out of Patterson-UTI (PTEN) in Q1 2018, closing a stake of 699,280 shares — an estimated $16.1M sold.

Cramer Rosenthal McGlynn first reported a position in PTEN in Q1 2017 and held it in 4 quarters. The position peaked at $16.1M in Q4 2017. 327 funds tracked by Wall St. Rank hold PTEN as of Q1 2018.

  • Cramer Rosenthal McGlynn reported no remaining Patterson-UTI position as of Q1 2018 after selling out during the quarter.
  • Cramer Rosenthal McGlynn sold 699,280 Patterson-UTI shares in Q1 2018, an estimated $16.1M.
  • Cramer Rosenthal McGlynn first reported a position in Patterson-UTI in Q1 2017 and held it in 4 quarters.
  • Cramer Rosenthal McGlynn's Patterson-UTI position peaked at $16.1M in Q4 2017.
  • 327 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2018.

Based on Cramer Rosenthal McGlynn's 13F filing for Q1 2018, filed 15 May 2018.